caged dimebon analogs (ACB Blocks)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecaged dimebon analogs (ACB Blocks)
Drug Alias NameTD-0012TD-0023TD-0016
ClassificationSmall molecules
Mechanisms of ActionCholinesterase inhibitorsNeuroprotectantsSerotonin 7 (5-HT7) receptor modulators +[4] 
TargetsSerotonin 7 (5-HT7) receptorCholinesteraseSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesACB Blocks Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesACB Blocks Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A